| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)
TORNTPHARM Technical Analysis
5
| As on 25th Apr 2024 TORNTPHARM SHARE Price closed @ 2694.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2150.89 & Strong Buy for SHORT-TERM with Stoploss of 2615.77 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TORNTPHARMSHARE Price
| Open | 2691.90 | Change | Price | % |
| High | 2702.05 | 1 Day | 7.85 | 0.29 |
| Low | 2672.00 | 1 Week | 147.45 | 5.79 |
| Close | 2694.30 | 1 Month | 134.50 | 5.25 |
| Volume | 137290 | 1 Year | 1052.00 | 64.06 |
| 52 Week High 2948.55 | 52 Week Low 1459.85 | ||||
| TORNTPHARM CURRENT MONTH FUTURE | |||
| Close | 2696.20 | ||
| Contracts Traded | 334500 | ||
| Open Intrest | 20000 | ||
| Change In O.I | -91.07 % | ||
| Lot Size | 500 | ||
| TORNTPHARM CURRENT MONTH OPTION | |
| Most Active Call | 2800.00 |
| Most Active put | 2400.00 |
| Highest O.I Buildup Call | 2800.00 |
| Highest O.I Buildup Put | 2400.00 |
| Expiry Date | 2024-04-25 |
| TORNTPHARM ALL MONTHS OPTIONS | |||
| For All TORNTPHARM Options Click Here | |||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| TORNTPHARM Daily Charts |
TORNTPHARM Intraday Charts |
Whats New @ Bazaartrend |
TORNTPHARM Free Analysis |
|
|
TORNTPHARM Important Levels Intraday
| RESISTANCE | 2752.21 |
| RESISTANCE | 2733.64 |
| RESISTANCE | 2722.16 |
| RESISTANCE | 2710.68 |
| SUPPORT | 2677.92 |
| SUPPORT | 2666.44 |
| SUPPORT | 2654.96 |
| SUPPORT | 2636.39 |
TORNTPHARM Target April 2024
| 4th UP Target | 3278.93 |
| 3rd UP Target | 3083.21 |
| 2nd UP Target | 2962.23 |
| 1st UP Target | 2841.25 |
| 1st DOWN Target | 2496.05 |
| 2nd DOWN Target | 2375.07 |
| 3rd DOWN Target | 2254.09 |
| 4th DOWN Target | 2058.37 |
TORNTPHARM Weekly Target
| 4th UP Target | 2740.77 |
| 3rd UP Target | 2676.19 |
| 2nd UP Target | 2636.27 |
| 1st UP Target | 2596.35 |
| 1st DOWN Target | 2482.45 |
| 2nd DOWN Target | 2442.53 |
| 3rd DOWN Target | 2402.61 |
| 4th DOWN Target | 2338.03 |
TORNTPHARM Target2024
| 4th UP Target | 3971.63 |
| 3rd UP Target | 3437.31 |
| 2nd UP Target | 3107.03 |
| 1st UP Target | 2776.76 |
| 1st DOWN Target | 1834.34 |
| 2nd DOWN Target | 1504.07 |
| 3rd DOWN Target | 1173.79 |
| 4th DOWN Target | 639.47 |
Torrent Pharmaceuticals Limited ( NSE INDIA Symbol : TORNTPHARM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TORNTPHARM Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 30.80 | Sideways | |
| MFI (14) | MFI is 30.36 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 2151.24 | |
| 10 Day Avg Volume | Traded 1.26 % More then 10 Day Average Volume | ||
TORNTPHARM Other Details
| Segment | EQ | |
| Market Capital | 472606015488.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-General | |
| Offical website | > | |
TORNTPHARM Address
 |
||
TORNTPHARM Latest News
TORNTPHARM Business Profile
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also offers contract manufacturing services. It has collaboration agreements with Cipla Limited, Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Limited, and Sun Pharmaceutical Industries Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in an outpatient setting. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited. Address: Torrent House, Ahmedabad, India, 380009
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service